Your browser doesn't support javascript.
loading
At Least Three Doses of Leading Vaccines Essential for Neutralisation of SARS-CoV-2 Omicron Variant.
Singanallur, Nagendrakumar B; van Vuren, Petrus Jansen; McAuley, Alexander J; Bruce, Matthew P; Kuiper, Michael J; Gwini, Stella M; Riddell, Shane; Goldie, Sarah; Drew, Trevor W; Blasdell, Kim R; Tachedjian, Mary; Mangalaganesh, Shruthi; Chahal, Simran; Caly, Leon; Druce, Julian D; Juno, Jennifer A; Kent, Stephen J; Wheatley, Adam K; Vasan, Seshadri S.
  • Singanallur NB; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness (ACDP), Geelong, VIC, Australia.
  • van Vuren PJ; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness (ACDP), Geelong, VIC, Australia.
  • McAuley AJ; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness (ACDP), Geelong, VIC, Australia.
  • Bruce MP; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness (ACDP), Geelong, VIC, Australia.
  • Kuiper MJ; Data61, Commonwealth Scientific and Industrial Research Organisation (CSIRO), Docklands, VIC, Australia.
  • Gwini SM; University Hospital Geelong, Barwon Health, Geelong, VIC, Australia.
  • Riddell S; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness (ACDP), Geelong, VIC, Australia.
  • Goldie S; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness (ACDP), Geelong, VIC, Australia.
  • Drew TW; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness (ACDP), Geelong, VIC, Australia.
  • Blasdell KR; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness (ACDP), Geelong, VIC, Australia.
  • Tachedjian M; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness (ACDP), Geelong, VIC, Australia.
  • Mangalaganesh S; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness (ACDP), Geelong, VIC, Australia.
  • Chahal S; Monash Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
  • Caly L; Commonwealth Scientific and Industrial Research Organisation (CSIRO), Australian Centre for Disease Preparedness (ACDP), Geelong, VIC, Australia.
  • Druce JD; Victorian Infectious Diseases Reference Laboratory (VIDRL), The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Juno JA; Victorian Infectious Diseases Reference Laboratory (VIDRL), The Peter Doherty Institute for Infection and Immunity, Melbourne, VIC, Australia.
  • Kent SJ; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
  • Wheatley AK; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
  • Vasan SS; Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Melbourne, VIC, Australia.
Front Immunol ; 13: 883612, 2022.
Article en En | MEDLINE | ID: mdl-35655773
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Vacunas Virales / COVID-19 Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article